PARTERNSHIP ID SOLUTIONS – STILLA
ID SOLUTIONS, a French company, offers an innovative, reliable and standardized tool for research and development tool in oncology diagnosis on circulating cell-free DNA from liquid biopsies and tumor DNA from solid biopsies . The IDENTIFY kits allow to detect multiplexed mutation panels using a fully validated, specific and sensitive digital PCR (DPCR) with the Stilla platform.
Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next generation genetic tests by providing a groundbreaking and flexible digital PCR (dPCR) solution.
Through this partnership, the two French companies aim to offer standard operating procedures, diagnostic and theranostic tools with high sensitivity to meet current clinical needs and requirements in oncology .